Tapewire

Nasdaq · USD

NSPR

InspireMD, Inc.

Export transactions ↓
Tapewire entity
7318
SEC CIK
0001433607
Parsed reports
164

Last 12 months

Inside the activity.

18 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202540
Jan 202609
Feb 202602
Mar 202600
Apr 202600
May 2026131
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 09, 2025 Filed Feb 23, 2026 21:05 UTC Amendment
Stuka PaulDirector
PurchaseCommon Stock 2,710 $1.81 $4,905.10
Disclosure

SEC source: 0001493152-26-007752 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 391,628

F1 · shares: This Form 4/A amends the Form 4 filed on December 11, 2025 solely to correct the number of shares reported in Table I, Column 4. The number of shares reported in Column 5 was correct as originally filed. No other changes have been made.

F2 · price: The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.80 to $1.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
December 05, 2025 Filed Dec 8, 2025 21:05 UTC
Stuka PaulDirector
PurchaseCommon Stock 5,073 $1.86 $9,435.78
Disclosure

SEC source: 0001493152-25-026629 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,918

Read SEC document
December 04, 2025 Filed Dec 5, 2025 21:05 UTC
Stuka PaulDirector
PurchaseCommon Stock 10,130 $1.85 $18,740.50
Disclosure

SEC source: 0001493152-25-026356 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,845

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:05 UTC
Stuka PaulDirector
PurchaseCommon Stock 13,431 $1.62 $21,758.22
Disclosure

SEC source: 0001493152-25-022284 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,715

Read SEC document
October 07, 2025 Filed Oct 9, 2025 20:05 UTC GrantCommon Stock 48,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-017587 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 656,425

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on October 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 20:20 UTC GrantOptions to purchase common stock (right to buy) · Derivative 19,041 $0.00 Strike: $2.38 $0.00
Disclosure

SEC source: 0001493152-25-013888 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,041

Underlying: Common Stock · 19,041 shares

Expires 2027-09-15

Read SEC document
September 15, 2025 Filed Sep 17, 2025 20:20 UTC GrantCommon Stock 37,815 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-013888 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,573

F1 · shares: Represent grant of shares of common stock for services rendered as a director of the issuer in 2025 prior to the Reporting Person's resignation as a director, effective September 16, 2025.

Read SEC document
July 30, 2025 Filed Aug 1, 2025 21:00 UTC PurchaseCommon Stock 41,322 $2.42 $99,999.24
Disclosure

SEC source: 0001641172-25-021934 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 608,425

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

F2 · price: The purchase price per share of common stock in the Private Placement was $2.42.

Read SEC document
July 30, 2025 Filed Aug 1, 2025 21:00 UTC
Slosman MarvinDirector · CEO and President
PurchaseCommon Stock 10,330 $2.42 $24,998.60
Disclosure

SEC source: 0001641172-25-021931 · ownership.xml · nonDerivative · entry 1

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,420,866

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

F2 · price: The purchase price per share of common stock in the Private Placement was $2.42.

Read SEC document
July 30, 2025 Filed Aug 1, 2025 21:00 UTC PurchaseCommon Stock 30,991 $2.42 $74,998.22
Disclosure

SEC source: 0001641172-25-021933 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,758

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

F2 · price: The purchase price per share of common stock in the Private Placement was $2.42.

Read SEC document
July 30, 2025 Filed Aug 1, 2025 21:00 UTC
Stuka PaulDirector
PurchaseCommon Stock 20,661 $2.42 $49,999.62
Disclosure

SEC source: 0001641172-25-021930 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 444,195

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").

F2 · price: The purchase price per share of common stock in the Private Placement was $2.42.

F3 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
July 11, 2025 Filed Jul 23, 2025 20:05 UTC OtherSeries I Warrant (right to buy) · Derivative 30,624 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001641172-25-020694 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,624 shares

Expires 2025-07-23

Read SEC document
July 11, 2025 Filed Jul 23, 2025 20:05 UTC OtherCommon Stock 30,624 $1.38 $42,343.80
Disclosure

SEC source: 0001641172-25-020694 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,767

Read SEC document
July 01, 2025 Filed Jul 23, 2025 20:05 UTC
Stuka PaulDirector
OtherSeries I Warrant (right to buy) · Derivative 87,500 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001641172-25-020693 · ownership.xml · derivative · entry 3

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 87,500 shares

Expires 2025-07-23

F1 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
July 01, 2025 Filed Jul 23, 2025 20:05 UTC
Stuka PaulDirector
OtherCommon Stock 87,500 $1.38 $120,986.25
Disclosure

SEC source: 0001641172-25-020693 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 423,534

F1 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
June 29, 2025 Filed Jul 23, 2025 20:05 UTC OtherSeries I Warrant (right to buy) · Derivative 61,248 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001641172-25-020695 · ownership.xml · derivative · entry 3

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 61,248 shares

Expires 2025-07-23

F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
June 29, 2025 Filed Jul 23, 2025 20:05 UTC OtherCommon Stock 61,248 $1.38 $84,687.61
Disclosure

SEC source: 0001641172-25-020695 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 244,994

F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
June 25, 2025 Filed Jul 23, 2025 20:05 UTC OtherSeries I Warrant (right to buy) · Derivative 30,624 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001641172-25-020692 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,624 shares

Expires 2025-07-23

Read SEC document
June 25, 2025 Filed Jul 23, 2025 20:05 UTC OtherCommon Stock 30,624 $1.38 $42,343.80
Disclosure

SEC source: 0001641172-25-020692 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 567,103

Read SEC document
May 30, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 7,186 $2.51 $18,036.86
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 12

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,079,601

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
May 29, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 3,760 $2.51 $9,437.60
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 11

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,086,787

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
May 27, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 1,572 $2.51 $3,945.72
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 10

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,090,547

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
May 23, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 2,482 $2.51 $6,229.82
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 9

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,092,119

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
February 25, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 10,000 $3.65 $36,500.00
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 8

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,094,601

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
February 04, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 5,132 $2.46 $12,624.72
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 7

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,104,601

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
February 03, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 7,073 $2.51 $17,753.23
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 6

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,109,733

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
January 31, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 9,923 $2.55 $25,303.65
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 5

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,116,806

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
January 30, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 2,454 $2.51 $6,159.54
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 4

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,126,729

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
January 29, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 3,660 $2.46 $9,003.60
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 3

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,129,183

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
January 28, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 2,476 $2.61 $6,462.36
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 2

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,132,843

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
January 27, 2025 Filed May 21, 2026 21:16 UTC
Gleason Shane ThomasChief Commercial Officer
SaleCommon Stock 3,858 $2.71 $10,455.18
Disclosure

SEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 1

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,135,319

F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantOptions to purchase common stock (right to buy) · Derivative 14,836 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001729 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,743

Underlying: Common Stock · 14,836 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantCommon Stock 32,491 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001729 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 534,279

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantOptions to purchase common stock (right to buy) · Derivative 7,418 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001735 · ownership.xml · derivative · entry 2

Ward Scott R. · CIK 0001174531 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,065

Underlying: Common Stock · 7,418 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantCommon Stock 16,245 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001735 · ownership.xml · nonDerivative · entry 1

Ward Scott R. · CIK 0001174531 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,793

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 16:30 UTC GrantOptions to purchase common stock (right to buy) · Derivative 14,836 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001725 · ownership.xml · derivative · entry 2

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,945

Underlying: Common Stock · 14,836 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 16:30 UTC GrantCommon Stock 32,491 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001725 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,531

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Slosman MarvinDirector · CEO and President
GrantOptions to purchase common stock (right to buy) · Derivative 254,985 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001731 · ownership.xml · derivative · entry 2

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 937,796

Underlying: Common Stock · 254,985 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Slosman MarvinDirector · CEO and President
GrantRestricted Stock Units 558,417 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001731 · ownership.xml · nonDerivative · entry 1

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,410,536

F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Tommasoli AndreaChief Operating Officer
GrantOptions to purchase common stock (right to buy) · Derivative 106,218 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001733 · ownership.xml · derivative · entry 2

Tommasoli Andrea · CIK 0001969462 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,917

Underlying: Common Stock · 106,218 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Tommasoli AndreaChief Operating Officer
GrantCommon Stock 232,616 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001733 · ownership.xml · nonDerivative · entry 1

Tommasoli Andrea · CIK 0001969462 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 727,694

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantOptions to purchase common stock (right to buy) · Derivative 14,836 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001728 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,947

Underlying: Common Stock · 14,836 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantCommon Stock 32,491 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001728 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 359,143

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Stuka PaulDirector
GrantOptions to purchase common stock (right to buy) · Derivative 22,254 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001732 · ownership.xml · derivative · entry 3

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,129

Underlying: Common Stock · 22,254 shares

Expires 2035-01-07

F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Stuka PaulDirector
GrantCommon Stock 48,736 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001732 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,284

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Verta PatrickEVP Clinical/Medical Affairs
GrantOptions to purchase common stock (right to buy) · Derivative 37,933 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001734 · ownership.xml · derivative · entry 2

Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,281

Underlying: Common Stock · 37,933 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Verta PatrickEVP Clinical/Medical Affairs
GrantCommon Stock 83,072 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001734 · ownership.xml · nonDerivative · entry 1

Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,532

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Gleason Shane ThomasChief Commercial Officer
GrantOptions to purchase common stock (right to buy) · Derivative 106,218 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001727 · ownership.xml · derivative · entry 2

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,346

Underlying: Common Stock · 106,218 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Gleason Shane ThomasChief Commercial Officer
GrantCommon Stock 232,616 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001727 · ownership.xml · nonDerivative · entry 1

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 746,981

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantOptions to purchase common stock (right to buy) · Derivative 14,836 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001726 · ownership.xml · derivative · entry 3

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,950

Underlying: Common Stock · 14,836 shares

Expires 2035-01-07

F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.